Topics

Astellas Buys Audentes for $3 Billion to Expand into Gene Therapy

19:00 EST 2 Dec 2019 | BioSpace

The merger is an effort on the part of Astellas to strengthen its genetic medicine and gene therapy business.

Original Article: Astellas Buys Audentes for $3 Billion to Expand into Gene Therapy

NEXT ARTICLE

More From BioPortfolio on "Astellas Buys Audentes for $3 Billion to Expand into Gene Therapy"

Quick Search

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...